Cargando…

Rapid and Accurate Detection of Escherichia coli and Klebsiella pneumoniae Strains Susceptible/Resistant to Cotrimoxazole through Evaluation of Cell Elongation

Trimethoprim-sulfamethoxazole is a well-known antibiotic that inhibits folic acid synthesis, a topic of renewed interest. Since resistant strains are increasingly more common, an early and accurate discrimination of susceptibility may assure confident therapy. Two morphological assays were performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	López, Isidoro, Otero, Fátima, Guillén, Rebeca, Fernández, María del Carmen, Bou, Germán, Gosálvez, Jaime, Fernández, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232604/ https://www.ncbi.nlm.nih.gov/pubmed/34203917 http://dx.doi.org/10.3390/antibiotics10060720

Ejemplares similares

Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay
por: Tamayo, María, et al.
Publicado: (2009)

A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis
por: Santiso, Rebeca, et al.
Publicado: (2011)

Comparison of ciprofloxacin, cotrimoxazole, and doxycycline on Klebsiella pneumoniae: Time-kill curve analysis
por: Setiawan, Andy, et al.
Publicado: (2022)

Comparative Proteomics Demonstrates Altered Metabolism Pathways in Cotrimoxazole- Resistant and Amikacin-Resistant Klebsiella pneumoniae Isolates
por: Shen, Chunmei, et al.
Publicado: (2021)

2261. Impact of Antimicrobial Stewardship Program on Klebsiella pneumoniae and Escherichia coli Antimicrobial Resistance
por: Ferreiro, Jose Luis Lamas, et al.
Publicado: (2023)

Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data
por: Stoesser, N., et al.
Publicado: (2013)

Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible
por: Baker, Thomas M, et al.
Publicado: (2018)

ChloS-HRM, a novel assay to identify chloramphenicol-susceptible Escherichia coli and Klebsiella pneumoniae in Malawi
por: Williams, Christopher T, et al.
Publicado: (2019)

Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda
por: Najjuka, Christine F., et al.
Publicado: (2016)

Phenotypic and molecular characterization of ESBL producing Escherichia coli and Klebsiella pneumoniae among Lebanese patients
por: El-Hariri, Saria A, et al.
Publicado: (2023)

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
por: Zahlanie, Yorgo, et al.
Publicado: (2021)

Cotrimoxazole‐induced hyperkalemia in renal transplant patient—Case report
por: Srikaram, Prakhyath, et al.
Publicado: (2022)

Successful treatment of cerebral toxoplasmosis with cotrimoxazole
por: Patil, Harsha V., et al.
Publicado: (2011)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

Prevalence and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital
por: Kader, Abdulrahman Abdulla, et al.
Publicado: (2005)

Comparison of Escherichia coli and Klebsiella pneumoniae Acute Pyelonephritis in Korean Patients
por: Hyun, Miri, et al.
Publicado: (2019)

ESBL‐production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria
por: Hertz, Frederik B., et al.
Publicado: (2019)

Rapid Detection of Piperacillin-Tazobactam Resistance in Klebsiella pneumoniae and Escherichia coli
por: Ortiz de la Rosa, José Manuel, et al.
Publicado: (2023)

Slowdown of Translational Elongation in Escherichia coli under Hyperosmotic Stress
por: Dai, Xiongfeng, et al.
Publicado: (2018)

1061. Decreased Utilization of Piperacillin–Tazobactam for Escherichia coli and Klebsiella Bacteremia due to Selective Susceptibility Reporting
por: Zahlanie, Yorgo, et al.
Publicado: (2019)

Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients
por: Zhang, Hui, et al.
Publicado: (2017)

Determining the susceptibility of carbapenem resistant Klebsiella pneumoniae and Escherichia coli strains against common disinfectants at a tertiary hospital in China
por: Chen, Yili, et al.
Publicado: (2020)

Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China
por: Zhang, Qi, et al.
Publicado: (2023)

Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014)

Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021)

New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada
por: Mulvey, Michael R., et al.
Publicado: (2011)

Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2018)

Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
por: Stoesser, N., et al.
Publicado: (2017)

Antibiotic Consumption in Hospitals and Resistance Rate of Klebsiella pneumoniae and Escherichia coli in Montenegro
por: Mijović, Gordana, et al.
Publicado: (2020)

Frequency of Beta-Lactamase Antibiotic Resistance Genes in Escherichia Coli and Klebsiella pneumoniae
por: Golsha, Roghieh, et al.
Publicado: (2021)

Colistin resistance in Escherichia coli and Klebsiella pneumoniae in humans and backyard animals in Ecuador
por: Bastidas-Caldes, Carlos, et al.
Publicado: (2023)

Inhibiting translation elongation can aid genome duplication in Escherichia coli
por: Myka, Kamila K., et al.
Publicado: (2017)

Cotrimoxazole/pentamidine: Lack of efficacy in Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

652. Comparison of fosfomycin (FOF) activity and prevalence of subpopulations between Escherichia coli (EC) and Klebsiella pneumoniae (KP) during susceptibility testing
por: Anderson, Jadyn C, et al.
Publicado: (2020)

Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of Anyigba, Nigeria
por: Mofolorunsho, Kehinde C, et al.
Publicado: (2021)

1228. Outcomes Associated with Empiric Cefepime or Meropenem for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae
por: Frescas, Brian E, et al.
Publicado: (2021)

Comparative in vitro activity of piperacillin-tazobactam and temocillin against third-generation cephalosporin-resistant, carbapenem-susceptible Escherichia coli and Klebsiella pneumoniae
por: Kresken, Michael, et al.
Publicado: (2021)

Combined Silymarin and Cotrimoxazole Therapy Attenuates Pulmonary Fibrosis in Experimental Paracoccidioidomycosis
por: Resende, Victor Quinholes, et al.
Publicado: (2022)

Detection and Characterization of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae from Hospital Effluents of Ouagadougou, Burkina Faso
por: Kagambèga, Alix Bénédicte, et al.
Publicado: (2023)

European Committee on Antimicrobial Susceptibility Testing-Recommended Rapid Antimicrobial Susceptibility Testing of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus From Positive Blood Culture Bottles
por: Park, Jong-Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f0dtilervp308cob9m2tn0nn14